PTC Therapeutics | Ventes

Sales Changement Date
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
Amgen USD 7.45B 746M 2024-03
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Cytokinetics USD 1.67M 1.29M 2023-12
Daiichi Sankyo JPY 409.62B 37.3B 2024-03
Gilead Sciences USD 7.12B 64M 2023-12
Incyte USD 880.89M 132.45M 2024-03
Ionis Pharmaceuticals USD 119M 206M 2024-03
Ironwood Pharmaceuticals USD 117.55M 3.81M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.9B 651M 2024-03
PTC Therapeutics USD 210.12M 96.94M 2024-03
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 413.5M 16.72M 2024-03
TG Therapeutics USD 63.5M 19.53M 2024-03
Ultragenyx Pharmaceutical USD 108.8M 18.59M 2024-03
Vertex Pharmaceuticals USD 2.69B 172.3M 2024-03
Xencor USD 44.69M 14.48M 2023-12



PTC Therapeutics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2024.